MCT4 silencing led to a concomitant loss in the expression of CD147, an ancillary protein necessary for MCT activity 35 that is required for in vivo growth of colon carcinoma 16 and pancreatic 36 cancer cells. Here, SLC16A1 is linked to cancer.